IHEAL Trial: Effectiveness of a Health Promotion Intervention for Women Who Have Experienced Intimate Partner Violence

April 26, 2021 updated by: Western University, Canada

iHEAL in Context: Effectiveness of a Health Promotion Intervention for Women Who Have Experienced Intimate Partner Violence (iHEAL Trial)

Living with an abusive partner has many negative impacts on women's health, safety and the quality of their lives. These issues often continue when women separate, or take steps to separate, from an abusive partner, and can make it more difficult to create a new life. However, few supports are available to help women manage their health and other challenges around the time of separation.

The Intervention for Health Enhancement and Living (iHEAL) was specifically developed to support women at this time. In iHEAL, women work with a Registered Nurse on issues that affect that their health and well-being in 10 and 18 visits that take place in a safe, private location over a 6 month period. The woman decides which issues she would like to work on, with nurses providing personalized help and support that fits with the woman's needs, goals and wishes. This includes helping her connect to local services if she chooses.

The purpose of this study is to learn whether iHEAL can improve the health and quality of life of women who have separated, or are taking steps to separate, from an abusive partner. To do this, 280 Canadian women from 3 provinces will be offered either iHEAL nurse visits or information about community services that they can use on their own. All participants will complete online surveys when they first start the study and 6 12, and 18 months later to examine whether there are changes in their health, quality of life, confidence and/or control. We also want to learn whether iHEAL is more helpful for some groups of women and whether any benefits to women that are identified outweigh the costs of providing the intervention. A small group of ~30-40 women will be asked to take part in an interview about what is was like to take part in this study when they complete the trial so that we can learn how to further improve iHEAL.

Study Overview

Status

Active, not recruiting

Detailed Description

As above

Study Type

Interventional

Enrollment (Actual)

331

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6T 2B5
        • University of British Columbia
    • New Brunswick
      • Fredericton, New Brunswick, Canada
        • University of New Brunswick
    • Ontario
      • London, Ontario, Canada, N6A 3C1
        • Western University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Woman
  • 19 years of age or older
  • Able to speak, read and understand English
  • Residing in specific communities in Ontario, British Columbia or New Brunswick
  • Planning to remain in area for next 6 months
  • Experienced physical, sexual, and/or psychological abuse, including coercive control from a current or former partner in the previous 12 months
  • Planning to separate OR in the process of separating OR separated from an abusive partner in the previous 3 years
  • Has access to the internet, and a safe computer, tablet, or smart phone
  • Has a safe email address

Exclusion Criteria:

  • Man
  • Under 19 years of age
  • Cannot read, speak, understand English
  • Living outside of the selected study sites, or living in the area but planning to relocate within 6 months
  • No experience of physical, sexual, or psychological abuse, including coercive control, from a current or former partner in the previous 12 months
  • Planning to stay with an abusive partner OR separated more than 3 years ago
  • No access to the internet, or safe computer, tablet or smart phone
  • No access to safe email and mailing address

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: iHEAL
10-18 visits (over 6 months) with a Registered Nurse
Women work with a Registered Nurse in 10-18 visits (over 6 months) that focus on 6 inter-related 6 components (areas): Safeguarding, Managing Symptoms, Getting Basics, Cautiously Connecting, Regenerating Family, Renewing Self. Using a standard 3 phase process, and guided by 5 principles, the nurse discusses each of these components with the woman in order to identify the woman's needs, experiences and priorities. The nurse then provides personalized support to assist the woman in address the concerns that she sees as most important for her health and well-being; this support includes linking women to existing services if she chooses.
Active Comparator: Usual Care
Information about Community Services
Women are provided with information about community services appropriate for women experiencing intimate partner violence and consistent with what service providers might recommend (usual care). Women are encouraged to use this information as they see fit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Quality of Life on the Quality of Life Scale (Sullivan)
Time Frame: baseline, 6 months
9 item self-report measure developed to assess quality of life across domains important to women who have experienced intimate partner violence. Total scores range from 9 to 63. Higher scores reflect higher levels of quality of life.
baseline, 6 months
Changes in PTSD Symptomology on the PTSD Checklist (Civilian Version)
Time Frame: baseline, 6 months
17 item self-report measure of PTSD symptoms designed for use in community samples and to assess probability of meeting diagnostic criteria for PTSD.
baseline, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Quality of Life on the Quality of Life Scale (Sullivan)
Time Frame: baseline, 12 months
9 item self-report measure developed to assess quality of life across domains important to women who have experienced intimate partner violence
baseline, 12 months
Changes in Quality of Life on the Quality of Life Scale (Sullivan)
Time Frame: Baseline, 18 months
9 item self-report measure developed to assess quality of life across domains important to women who have experienced intimate partner violence
Baseline, 18 months
Changes in PTSD Symptomology on the PTSD Checklist (Civilian Version)
Time Frame: Baseline, 12 months
17 item self-report measure of PTSD symptoms designed for use in community samples and to assess probability of meeting diagnostic criteria for PTSD
Baseline, 12 months
Changes in PTSD Symptomology on the PTSD Checklist (Civilian Version)
Time Frame: Baseline, 18 months
17 item self-report measure of PTSD symptoms designed for use in community samples and to assess probability of meeting diagnostic criteria for PTSD
Baseline, 18 months
Changes in Depressive Symptoms on the Center for Epidemiologic Studies Depression Scale, Revised (CESD-R).
Time Frame: Baseline, 6 months
20 item self-report measure of depressive symptoms in community samples, including probability of meeting criteria for major depressive disorder. Total scores range from 0 to 60. Higher scores reflect higher levels of depressive symptoms.
Baseline, 6 months
Changes in Depressive Symptoms on the Center for Epidemiologic Studies Depression Scale, Revised
Time Frame: Baseline, 12 months
20 item self-report measure of depressive symptoms in community samples, including probability of meeting criteria for major depressive disorder
Baseline, 12 months
Changes in Depressive Symptoms on the Center for Epidemiologic Studies Depression Scale, Revised
Time Frame: Baseline, 18 months
20 item self-report measure of depressive symptoms in community samples, including probability of meeting criteria for major depressive disorder
Baseline, 18 months
Changes in Chronic Pain Disability on the Chronic Pain Grade (van Korff)
Time Frame: Baseline, 6 months
7 item self-report measure of chronic pain intensity and disability, including 4 "grades" that capture level of disability (from no to high)
Baseline, 6 months
Changes in Chronic Pain Disability on the Chronic Pain Grade (van Korff)
Time Frame: Baseline, 12 months
7 item self-report measure of chronic pain intensity and disability, including 4 "grades" that capture level of disability (from no to high)
Baseline, 12 months
Changes in Chronic Pain Disability on the Chronic Pain Grade (van Korff)
Time Frame: Baseline, 18 months
7 item self-report measure of chronic pain intensity and disability, including 4 "grades" that capture level of disability (from no to high)
Baseline, 18 months
Changes in Personal Control on the Personal Agency Scale (Smith)
Time Frame: Baseline, 6 months
8 item self-report scale that measures an individual's sense of control and efforts to act on their own behalf. Total scores range from 8 to 32. Higher scores reflect higher levels of personal agency.
Baseline, 6 months
Changes in Personal Control on the Personal Agency Scale (Smith)
Time Frame: Baseline, 12 months
8 item self-report scale that measures an individual's sense of control and efforts to act on their own behalf. Total scores range from 8 to 32. Higher scores reflect higher levels of personal agency.
Baseline, 12 months
Changes in Personal Control on the Personal Agency Scale (Smith)
Time Frame: Baseline, 18 months
8 item self-report scale that measures an individual's sense of control and efforts to act on their own behalf. Total scores range from 8 to 32. Higher scores reflect higher levels of personal agency.
Baseline, 18 months
Changes in Confidence (self-efficacy) on investigator-developed scale
Time Frame: Baseline, 6 months
10 item self-report scale that measures women's confidence in engaging in a set of actions that fit with key goals of the iHEAL on 100 mm visual analogue scales. total scores range from 0 to 100. Higher scores reflect higher levels of confidence.
Baseline, 6 months
Changes in Confidence (self-efficacy) on investigator-developed scale
Time Frame: Baseline, 12 months
10 item self-report scale that measures women's confidence in engaging in a set of actions that fit with key goals of the iHEAL on 100 mm visual analogue scales. Total scores range from 0 to 100. Higher scores reflected higher levels of confidence.
Baseline, 12 months
Changes in Confidence (self-efficacy) on investigator-developed scale
Time Frame: Baseline, 18 months
10 item self-report scale that measures women's confidence in engaging in a set of actions that fit with key goals of the iHEAL on 100 mm visual analogue scales. Total scores range from 0 -100. Higher scores reflect higher levels of confidence.
Baseline, 18 months
Changes in Coercive Control on the Women's Experiences of Battering Scale (WEB)
Time Frame: Baseline, 6 months
10 item self-report measure of the intensity of coercive control experienced by women in response to intimate partner violence. Total scores range from 10 to 60. Higher scores reflect higher levels of experiences of coercive control.
Baseline, 6 months
Changes in Coercive Control on the Women's Experiences of Battering Scale (WEB)
Time Frame: Baseline, 12 months
10 item self-report measure of the intensity of coercive control experienced by women in response to intimate partner violence. Total scores range from 10 to 60. Higher scores reflect higher levels of experiences of coercive control.
Baseline, 12 months
Changes in Coercive Control on the Women's Experiences of Battering Scale (WEB)
Time Frame: Baseline, 18 months
10 item self-report measure of the intensity of coercive control experienced by women in response to intimate partner violence. Total scores range from 10-60. Higher scores reflect higher levels of experiences of coercive control.
Baseline, 18 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of Intimate Partner Violence on the Composite Abuse Scale Revised - Short Form (CASr-SF)
Time Frame: Baseline, 6, 12, 18 months
15 item validated measure of severity of intimate partner violence
Baseline, 6, 12, 18 months
Problem Drinking on the AUDIT
Time Frame: Baseline, 6, 12, 18 months
Self-report measure of alcohol mis-use
Baseline, 6, 12, 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 26, 2018

Primary Completion (Actual)

April 24, 2020

Study Completion (Anticipated)

May 22, 2021

Study Registration Dates

First Submitted

June 20, 2018

First Submitted That Met QC Criteria

June 20, 2018

First Posted (Actual)

June 29, 2018

Study Record Updates

Last Update Posted (Actual)

April 28, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intimate Partner Violence

3
Subscribe